161 related articles for article (PubMed ID: 23874020)
1. Covert operations: cancer's many subversive tactics in overcoming host defenses.
Longo DL
Trans Am Clin Climatol Assoc; 2013; 124():163-73. PubMed ID: 23874020
[TBL] [Abstract][Full Text] [Related]
2. Neoplastic "Black Ops": cancer's subversive tactics in overcoming host defenses.
Biragyn A; Longo DL
Semin Cancer Biol; 2012 Feb; 22(1):50-9. PubMed ID: 22257681
[TBL] [Abstract][Full Text] [Related]
3. A novel antigen delivery system induces strong humoral and CTL immune responses.
Yang Z; Xu M; Jia Z; Zhang Y; Wang L; Zhang H; Wang J; Song M; Zhao Y; Wu Z; Zhao L; Yin Z; Hong Z
Biomaterials; 2017 Jul; 134():51-63. PubMed ID: 28456076
[TBL] [Abstract][Full Text] [Related]
4. Characterization of effector components from the humoral and cellular immune response stimulated by melanoma cells exhibiting modified IGF-1 expression.
Zhu C; Trabado S; Fan Y; Trojan J; Lone YC; Giron-Michel J; Duc HT
Biomed Pharmacother; 2015 Mar; 70():53-7. PubMed ID: 25776479
[TBL] [Abstract][Full Text] [Related]
5. Type I IFN gene delivery suppresses regulatory T cells within tumors.
Hashimoto H; Ueda R; Narumi K; Heike Y; Yoshida T; Aoki K
Cancer Gene Ther; 2014 Dec; 21(12):532-41. PubMed ID: 25430879
[TBL] [Abstract][Full Text] [Related]
6. Thiol dependent NF-κB suppression and inhibition of T-cell mediated adaptive immune responses by a naturally occurring steroidal lactone Withaferin A.
Gambhir L; Checker R; Sharma D; Thoh M; Patil A; Degani M; Gota V; Sandur SK
Toxicol Appl Pharmacol; 2015 Dec; 289(2):297-312. PubMed ID: 26408225
[TBL] [Abstract][Full Text] [Related]
7. mTOR Promotes Antiviral Humoral Immunity by Differentially Regulating CD4 Helper T Cell and B Cell Responses.
Ye L; Lee J; Xu L; Mohammed AU; Li W; Hale JS; Tan WG; Wu T; Davis CW; Ahmed R; Araki K
J Virol; 2017 Feb; 91(4):. PubMed ID: 27974559
[TBL] [Abstract][Full Text] [Related]
8. The transcription factor Twist1 limits T helper 17 and T follicular helper cell development by repressing the gene encoding the interleukin-6 receptor α chain.
Pham D; Walline CC; Hollister K; Dent AL; Blum JS; Firulli AB; Kaplan MH
J Biol Chem; 2013 Sep; 288(38):27423-27433. PubMed ID: 23935104
[TBL] [Abstract][Full Text] [Related]
9. Tumor-induced oxidative stress perturbs nuclear factor-kappaB activity-augmenting tumor necrosis factor-alpha-mediated T-cell death: protection by curcumin.
Bhattacharyya S; Mandal D; Sen GS; Pal S; Banerjee S; Lahiry L; Finke JH; Tannenbaum CS; Das T; Sa G
Cancer Res; 2007 Jan; 67(1):362-70. PubMed ID: 17210719
[TBL] [Abstract][Full Text] [Related]
10. PD-1 blockade augments humoral immunity through ICOS-mediated CD4
Zhang M; Xia L; Yang Y; Liu S; Ji P; Wang S; Chen Y; Liu Z; Zhang Y; Lu S; Wang Y
Int Immunopharmacol; 2019 Jan; 66():127-138. PubMed ID: 30448635
[TBL] [Abstract][Full Text] [Related]
11. OX40 costimulation can abrogate Foxp3+ regulatory T cell-mediated suppression of antitumor immunity.
Kitamura N; Murata S; Ueki T; Mekata E; Reilly RT; Jaffee EM; Tani T
Int J Cancer; 2009 Aug; 125(3):630-8. PubMed ID: 19455675
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of T-cell-mediated antitumor response: angiostatic adjuvant to immunotherapy against cancer.
Dings RP; Vang KB; Castermans K; Popescu F; Zhang Y; Oude Egbrink MG; Mescher MF; Farrar MA; Griffioen AW; Mayo KH
Clin Cancer Res; 2011 May; 17(10):3134-45. PubMed ID: 21252159
[TBL] [Abstract][Full Text] [Related]
13. Anti-tumor immunity and mechanism of immunosuppression mediated by tumor cells: role of tumor-derived soluble factors and cytokines.
Deepak P; Acharya A
Int Rev Immunol; 2010 Aug; 29(4):421-58. PubMed ID: 20635882
[TBL] [Abstract][Full Text] [Related]
14. The impact of high anxiety level on cellular and humoral immunity in mice.
Rammal H; Bouayed J; Falla J; Boujedaini N; Soulimani R
Neuroimmunomodulation; 2010; 17(1):1-8. PubMed ID: 19816051
[TBL] [Abstract][Full Text] [Related]
15. Cellular and humoral immune responses during tuberculosis infection: useful knowledge in the era of biological agents.
Matucci A; Maggi E; Vultaggio A
J Rheumatol Suppl; 2014 May; 91():17-23. PubMed ID: 24788996
[TBL] [Abstract][Full Text] [Related]
16. Soluble CD80 Protein Delays Tumor Growth and Promotes Tumor-Infiltrating Lymphocytes.
Horn LA; Long TM; Atkinson R; Clements V; Ostrand-Rosenberg S
Cancer Immunol Res; 2018 Jan; 6(1):59-68. PubMed ID: 29122838
[TBL] [Abstract][Full Text] [Related]
17. The regulation of CD4+ T cell immune responses toward Th2 cell development by prostaglandin E2.
Bao YS; Zhang P; Xie RJ; Wang M; Wang ZY; Zhou Z; Zhai WJ; Feng SZ; Han MZ
Int Immunopharmacol; 2011 Oct; 11(10):1599-605. PubMed ID: 21635971
[TBL] [Abstract][Full Text] [Related]
18. Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.
Ohshio Y; Teramoto K; Hanaoka J; Tezuka N; Itoh Y; Asai T; Daigo Y; Ogasawara K
Cancer Sci; 2015 Feb; 106(2):134-42. PubMed ID: 25483888
[TBL] [Abstract][Full Text] [Related]
19. Role of STAT3 in CD4+CD25+FOXP3+ regulatory lymphocyte generation: implications in graft-versus-host disease and antitumor immunity.
Pallandre JR; Brillard E; Créhange G; Radlovic A; Remy-Martin JP; Saas P; Rohrlich PS; Pivot X; Ling X; Tiberghien P; Borg C
J Immunol; 2007 Dec; 179(11):7593-604. PubMed ID: 18025205
[TBL] [Abstract][Full Text] [Related]
20. Absence of host NF-κB p50 induces murine glioblastoma tumor regression, increases survival, and decreases T-cell induction of tumor-associated macrophage M2 polarization.
Barberi T; Martin A; Suresh R; Barakat DJ; Harris-Bookman S; Drake CG; Lim M; Friedman AD
Cancer Immunol Immunother; 2018 Oct; 67(10):1491-1503. PubMed ID: 30030559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
